Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Capital/Financing Update 2020

Sep 25, 2020

61842_rns_2020-09-25_b02484c4-7a41-41b9-8593-3295f6ca4939.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Communication Address: Solara Active Pharma Sciences Limited Batra Centre

No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in

September 25, 2020

The BSE Limited

Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001 Scrip Code: 541540

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Sandra (E), Mumbai - 400 051

Scrip Code: SOLARA

Dear Sir/ Madam,

Sub: Intimation of Credit rating

Pursuant to Regulation 30 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we write to inform you that CRISIL, Credit Rating Agency, vide press release dated September 25, 2020 has upgraded the rating for the following instruments of the Company:

1 Long Term Rating CRISIL A-/Stable (Upgraded from 'CRISIL BBB+/Positive') 2 Short Term Rating CRISIL A2+ (Upgraded from 'CRISIL A2')

The above is for your information and record.

Thanking you, Yours Truly, For Solara Active Pharma Sciences Limited S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942